Central venous access devices implantation in children with severe hemophilia a: data from the children comprehensive care center of China

Xu, Qian; Wang, Chunli; Cheng, W. S.; Zhen, Yi; Ding, Yunhua; Liu, Guoqing; Yao, Wanru; Chen, Zhenping; Li, Zhiqiang; Wu, Runhui

doi:10.1016/j.heliyon.2023.e13666

Cited by 1 publication

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literature confirms the widespread yet safe use of an implantable port-type intravenous system in pediatric patients requiring long-term treatment ( 4 – 7 , 24 – 27 ). The Seldinger method is described as a safe technique that allows the central vessel to be reached with relative ease ( 28 ).…”

Section: Discussionsupporting

confidence: 56%

Totally implantable venous ports in infants and children: a single-center retrospective study of indications and safety

Sosnowska-Sienkiewicz,

Moryciński,

Januszkiewicz-Lewandowska

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

IntroductionTotally Implantable Venous Access Devices (TIVADs) contribute significantly to the treatment progress and comfort of patients requiring long-term therapy. However, the procedure for implanting TIVADs, as well as its very presence, may be associated with complications.AimThis study evaluates the indications, safety, and complication rates of venous port implantations in pediatric patients. It also explores factors influencing the occurrence of early and late complications post-implantation.Materials and methodsThe study included 383 pediatric patients treated at the Department of Pediatric Surgery, Traumatology, and Urology in Poznan between 2013 and 2020 who underwent 474 implantations of intravenous ports. Venous access was achieved using the Seldinger technique. Statistical analysis was performed using Statistica 13 with TIBCO and PQStat 1.8.2.156 with PQStat.ResultsVenous ports were used in 345 oncology patients requiring chemotherapy (90% of the total group) and in 38 children (10%) with non-oncology indications. There were 36 early complications (7.6%) and 18 late complications (3.8%), excluding infectious complications. The most common early, non-infectious complications included pneumothorax (15 patients; 3%) and port pocket hematoma (12 patients; 2.5%). The most common late, non-infectious complications observed were venous catheter obstruction (8 children; 1.7%) and port system leakage (5 children; 1%). Infectious complications occurred in 129 cases (27.2%). Children with a diagnosis of non-Hodgkin’s lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia had a significantly higher incidence of port infections. Venous ports equipped with a polyurethane catheter, compared to systems with a silicone catheter, functioned significantly shorter.ConclusionsThe Seldinger method of port implantation is quick, minimally invasive, and safe. The type of port, including the material of the port’s venous catheter, and the underlying disease have an impact on the durability of implantable intravenous systems. The experience of the surgeon is related to the frequency of complications associated with the procedure.

show abstract